loader image
Monday, December 22, 2025
84.7 F
McAllen
- Advertisement -

Meningococcal Vaccination

Your questions answered

Translate to Spanish or other 102 languages!

Teens and young adults are at increased risk for meningococcal disease. Meningococcal disease is a very serious illness where death can occur in as little as a few hours. Talk with a doctor about meningococcal vaccination to help protect your child’s health. Image for illustration purposes
Teens and young adults are at increased risk for meningococcal disease. Meningococcal disease is a very serious illness where death can occur in as little as a few hours. Talk with a doctor about meningococcal vaccination to help protect your child’s health. Image for illustration purposes

Mega Doctor News

- Advertisement -

Teens and young adults are at increased risk for meningococcal disease. Meningococcal disease is a very serious illness where death can occur in as little as a few hours. Talk with a doctor about meningococcal vaccination to help protect your child’s health.

There are two types of meningococcal vaccines licensed in the United States:

  • Meningococcal conjugate (MenACWY) vaccines
  • Serogroup B meningococcal (MenB) vaccines

These vaccines help prevent the most common causes of meningococcal disease in the United States.

- Advertisement -

CDC recommends meningococcal vaccines for preteens, teens, and certain other people

CDC recommends MenACWY vaccine for:

  • All preteens at 11 to 12 years old
  • All teens at 16 years old

The booster dose at 16 years old gives teens continued protection during the ages when they are at highest risk.

Teens and young adults (16 through 23 year olds) may also get MenB vaccine.

  • Preferred age is 16 through 18 years old
  • Multiple doses needed for best protection
  • Must get the same brand for all doses

Younger children and adults usually do not need meningococcal vaccines. However, CDC recommends one or both types of meningococcal vaccines for people with

- Advertisement -
  • Certain medical conditions
  • Travel plans to areas where the disease is common
  • Jobs working with the bacteria
  • Increased risk due to a meningococcal disease outbreak

Meningococcal vaccines are safe but side effects can occur

About half of people who get a MenACWY vaccine have mild problems following vaccination:

  • Redness or pain where they got the shot
  • Fever

These reactions usually get better on their own within 1 to 2 days, but serious reactions are possible.

Following MenB vaccination, more than half of people who get the vaccine will have mild problems:

  • Soreness, redness, or swelling where they got the shot
  • Fatigue (tiredness)
  • Headache
  • Muscle or joint pain
  • Fever or chills
  • Nausea or diarrhea

These reactions usually get better on their own within 3 to 7 days, but serious reactions are possible.

Information source: CDC

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

6 Depression Symptoms in Midlife Linked to Almost 50% Higher Dementia Risk

In 2021, about 57 million people globally were living with dementia — an umbrella term for neurological conditions that impact a person’s cognitive skills and memory, such as Alzheimer’s disease and vascular dementia

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.
- Advertisement -
×